All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MPN Advocates Network
During the 2021 TCT Meetings Digital Experience, the MPN Hub spoke to Craig W. Freyer, University of Pennsylvania, Philadelphia, US. We asked, How should conditioning be performed before transplanting a patient with MF?
How should conditioning be performed before transplanting a patient with MF?
Freyer overviews research on different conditioning regimens for patients with myelofibrosis (MF) prior to allogeneic stem cell transplant. This includes comparing outcomes and tolerability of myeloablative versus reduced intensity conditioning, finding the optimal treatment combination, and outlining early data for an intermediate intensity conditioning regimen.
Post-transplant cyclophosphamide and ruxolitinib as GvHD prophylactic regimen in patients with primary or secondary myelofibrosis
In a study published in Acta Haematologica, Elena Vladislavovna Morozova and colleagues evaluated the combination of...
When should we give JAK inhibitors to patients with MF in the peri-transplant setting?
During the 2021 TCT Meetings Digital Experience, the MPN Hub spoke to Ruben A. Mesa, UT Health San Antonio, San Antonio, US. We asked, When should we give JAK...
Subscribe to get the best content related to MPN delivered to your inbox